2020 Virtual ESMO Review
2020 ESMO Update on UC: Does 1L Durvalumab +/- Tremelimumab Improve OS vs. SoC Chemo in Unresectable Advanced UC? Can Sacituzumab Govitecan Change Practice in mUC?
By
2020 Virtual ESMO Review
FEATURING
Manojkumar Bupathi
By
2020 Virtual ESMO Review
FEATURING
Manojkumar Bupathi
Comments 0
Login to view comments.
Click here to Login
